This information was initially shared on Wellcome's website.
This funding call will support multidisciplinary teams to generate evidence on where dengue and Zika viruses co-circulate and investigate the implications this has on host immune responses and clinical outcomes. Research funded through this award will support global efforts to understand and predict the spread of these pathogens, especially where data are limited. Funded projects will also help to design and implement future interventions to reduce dengue and Zika’s growing burden and impact on health.
- Lead applicant career stage: Mid-career researcher, Established researcher
- Administering organisation location: Anywhere in the world (apart from mainland China)
- Funding amount: Up to £5 million per award
- Funding duration: Between 3 to 5 years
The team must:
- Contain expertise in whole genome sequencing and analysis, and at least one of the following disciplines: epidemiology, immunology or public health.
- Have a lead applicant or coapplicant, from an African or Asian country that is currently experiencing a dengue and Zika outbreak or has experienced an outbreak in the past.
Please visit Wellcome's website for more details on eligibility, team requirements, and application process.
Preliminary application deadline is 25 June 2024.
Photo by Mithil Girish on Unsplash
Join the FEBS Network today
Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.